<DOC>
	<DOCNO>NCT00139906</DOCNO>
	<brief_summary>This study ass safety tolerability five-day titration schedule ( use twice daily dose first three day ) achieve high propose dose 40 mg daily . The study duration two month .</brief_summary>
	<brief_title>Twice Daily Titration Study Bifeprunox Subjects With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<criteria>Subjects current diagnosis Schizophrenia Schizoaffective disorder Body weight 100250 lbs Male female 1855 year age Subjects acutely psychotic Subjects current Axis I primary psychiatric diagnosis schizophrenia , significant risk suicide</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2006</verification_date>
	<keyword>Titration Study</keyword>
	<keyword>Schizophrenia</keyword>
	<keyword>BID dose</keyword>
	<keyword>Pharmacokinetic</keyword>
</DOC>